Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated about 9 hours ago
AI clinical monitoring agent can deliver up to 82 times the ROI in oncology: report
about 9 hours ago
A new analysis from the Tufts Center for the Study of Drug...
After slimming down workforce, Aardvark scraps phase 3 trials as wait for next steps drags on
about 15 hours ago
Aardvark Therapeutics has confirmed it is walking away from recently terminated phase...
Samsung hearing aid features for its ear buds garner FDA clearance
about 16 hours ago
The FDA gave Samsung Electronics the go-ahead for the latest software features...
Definium hits another phase 3 homerun with psychedelic ‘sea change’ for anxiety
about 18 hours ago
Definium Therapeutics’ LSD formula has gone two for two in its phase...
Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs
about 18 hours ago
Boulevard Bio has strolled out of stealth with $65 million in funding...
CytoDyn’s leronlimab reaffirms HIV potential after combo treatment eradicates virus in infant macaques
about 20 hours ago
CytoDyn's leronlimab may have struggled to secure approval as an HIV treatment...
Amgen lays groundwork for new R&D center in Hyderabad
1 day ago
Amgen is expanding its footprint in India with an R&D center in...
Epicrispr raises $90M to rewrite treatment of rare muscle disease
1 day ago
Epicrispr Biotechnologies has raised $90 million in a series C round backed...
Zydus’ Sentynl pens $475M deal for Mereo’s phase 3-ready rare genetic lung disease drug
1 day ago
Sentynl Therapeutics has penned a deal potentially worth $475 million for the...
Aura lays off 20% of workforce, rejigs C-suite amid R&D refocus on eye cancer
1 day ago
Aura Biosciences is refocusing under its recently installed CEO, laying off 20%...
Abbott teams with Google Health on AI-powered health insights app
1 day ago
Two giants of their respective fields, Abbott and Google, are joining forces...
Regeneron backs $75M series A for antibody upstart Infinimmune
1 day ago
Infinimmune has amassed further fuel to power its antibody discovery engine, netting...